First human test of new drug EA5 completed
Knowledge-focused
Completed
This was a very early, small study to see if a new drug called EA5 is safe for people and to learn how it moves through the body. It involved 28 healthy adults who received a single dose. The main goal was to check for side effects and measure drug levels in the blood to help pla…
Phase: PHASE1 • Sponsor: Shanghai Lanyi Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC